LTFS
FCSC

Ladenburg Thalmann Financial Services’s Fibrocell Science Inc. FCSC Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5
Closed – – 4033
2014
Q1 		$0 Hold
5
– – ﹤0.01% 3907
2013
Q4 		$0 Buy
+5
New +$291 ﹤0.01% 3901

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FCSC Position: Q2 2014 in Review

Ladenburg Thalmann Financial Services sold out of Fibrocell Science Inc. (FCSC) in Q2 2014, closing a stake of 5 shares.

Ladenburg Thalmann Financial Services first reported a position in FCSC in Q4 2013 and held it in 2 quarters. The position peaked at $0 in Q1 2014. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2014.

  • Ladenburg Thalmann Financial Services reported no remaining Fibrocell Science Inc. position as of Q2 2014 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 5 Fibrocell Science Inc. shares in Q2 2014.
  • Ladenburg Thalmann Financial Services first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 2 quarters.
  • Ladenburg Thalmann Financial Services's Fibrocell Science Inc. position peaked at $0 in Q1 2014.
  • 44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2014.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2014, filed 14 Aug 2014.